Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer

Fig. 2

Cell migration and MMP-2, − 9 activity in A549 and H1299 cells. Percent cell migration after PARP-1 inhibition with olaparib (O), DPQ (D) and combined with 12C ion in A549 (a) and H1299 (b) cells. Each bar with different pattern represents mean percent cell migration with standard deviation obtained from three independent experiments in triplicates. c-d-e Typical photograph of gelatin zymogram to determine MMP-2 (72 kDa) and MMP-9 (92 kDa) activity after exposure with 12C in presence and absence of DPQ (d) (c) or olaparib (O) (d) in A549 cells and H1299 (e) cells

Back to article page
\